Davis Polk & Wardwell is advising Gilead Sciences, Inc. on the transaction, and Cravath, Swaine & Moore is advising CymaBay Therapeutics, Inc. Gilead Sciences, Inc. (Gilead)...
Gilead Sciences’ $4.3 Billion Acquisition of CymaBay Therapeutics
TowerBrook Capital Partners’ Acquisition of IT Solutions Provider CBTS
Sidley Austin LLP represented TowerBrook Capital Partners L.P. on the transaction, and Cravath Swaine & Moore represented altafiber. TowerBrook Capital Partners (“TowerBrook”) annoubnced the acquisition of...
State Farm’s $1.2 Billion Investment in ADT
Cravath represented ADT in the transaction while Sidley advised State Farm. ADT Inc. (“ADT”) and State Farm announced that State Farm has agreed to make a...
Aramco’s $2.65 Billion Acquisition of the Global Products Business of Valvoline
White & Case advised Aramco, while Cravath, Swaine & Moore advised Valvoline on the deal. Aramco, one of the world’s largest integrated energy and chemical companies,...
Francisco Partners’ Acquisition of Healthcare Data and Analytics Assets from IBM
Cravath, Swaine & Moore represented IBM in the transaction, while Kirkland & Ellis advised Francisco Partners. IBM and Francisco Partners, a global investment firm that specializes...
Square, Inc.’s A$39 Billion Acquisition of Afterpay
Wachtell, Lipton, Rosen & Katz and King & Wood Mallesons are serving as legal advisors to Square. Gilbert + Tobin and Cravath, Swaine & Moore are...